4 December, 2017
Country of origin: 
Sector/Main field of activity: 
Medical & Healthcare
EEN profile reference: 
Type of request: 
Type of Partnership: 
Partnership type sought: 
Financial agreement
License agreement

A Japanese start-up venture has developed a naturally-derived anti-fungal drug compound aimed to cure the “nail athlete’s foot disease” that is twice more efficient than actual drugs.

The compound having cleared pre-clinical tests confirming the therapeutic effects, the company is now looking for financial support from EU partners for the clinical stage of the research and development process. A licensing agreement is also possible in addition to the financial one.

See the company profile for more details.

Contact details: 
EU-Japan Centre for Industrial Cooperation / info-eu@een-japan.eu